Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass

Marie Kostine¹, Léa Dousset², Thierry Schaeverbeke¹; FHU-ACRONIM

Affiliations

¹ Department of Rheumatology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
² Department of Dermatology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

PMID: 29925509
DOI: 10.1136/annrheumdis-2018-213682

Comment

Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass

Marie Kostine et al. Ann Rheum Dis. 2019 Jul.

. 2019 Jul;78(7):e71.

doi: 10.1136/annrheumdis-2018-213682. Epub 2018 Jun 20.

Authors

Marie Kostine¹, Léa Dousset², Thierry Schaeverbeke¹; FHU-ACRONIM

Affiliations

¹ Department of Rheumatology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
² Department of Dermatology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

PMID: 29925509
DOI: 10.1136/annrheumdis-2018-213682

No abstract available

Keywords: autoimmune diseases; polymyalgia rheumatica; treatment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM. Kostine M, et al. Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16. Ann Rheum Dis. 2018. PMID: 29146737
Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor.
Chan KK, Bass AR. Chan KK, et al. Ann Rheum Dis. 2019 Jul;78(7):e70. doi: 10.1136/annrheumdis-2018-213672. Epub 2018 May 14. Ann Rheum Dis. 2019. PMID: 29760158 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass

Affiliations

Response to: 'Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1/2 inhibitor' by Chan and Bass

Authors

Affiliations

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical